Section I. Authority
These regulations are promulgated pursuant to the authority
granted by Section
38-13-1030 of the Insurance
Law.
Section II. Purpose.
The purpose of these regulations is to set forth the procedures
for filing and the required contents of the Corporate Governance Annual
Disclosure (CGAD), deemed necessary by the Director to carry out the provisions
of Section 38--13-1000 et seq.
Section
III. Definitions.
A. "Director."
The South Carolina Director of Insurance or his designee.
B. "Insurance group." For the purpose of this
Act, the term "insurance group" shall mean those insurers and affiliates
included within an insurance holding company system as defined in Section
38-13-1000
et seq.
C. "Insurer." The term
"insurer" shall have the same meaning as set forth in Regulation
69-3,
except that it shall not include agencies, authorities or instrumentalities of
the United States, its possessions and territories, the Commonwealth of Puerto
Rico, the District of Columbia, or a state or political subdivision of a
state.
D. "Senior Management." The
term "senior management" shall mean any corporate officer responsible for
reporting information to the board of directors at regular intervals or
providing this information to shareholders or regulators and shall Include, for
example and without limitation, the Chief Executive Officer ("CEO"), Chief
Financial Officer ("CFO"), Chief Operations Officer ("COO"), Chief Procurement
Officer ("CPO"), Chief Legal Officer ("CLO"), Chief Information Officer
("CIO"), Chief Technology Officer ("CTO"), Chief Revenue Officer ("CRO"), Chief
Visionary Officer ("CVO"), or any other "C" level executive.
Section IV. Filing Procedures
A. An insurer, or the insurance group of
which the insurer is a member, required to file a CGAD by the Corporate
Governance Annual Disclosure Act, Section 38--13-1000 et seq., shall, no later
than June 1 of each calendar year, submit to the director a CGAD that contains
the information described in Section V of these regulations.
B. The CGAD must include a signature of the
insurer's or insurance group's chief executive officer or corporate secretary
attesting to the best of that individual's belief and knowledge that the
insurer or insurance group has implemented the corporate governance practices
and that a copy of the CGAD has been provided to the insurer's or insurance
group's Board of Directors (hereafter "Board") or at the appropriate committee
thereof.
C. The insurer or
insurance group shall have discretion regarding the appropriate format for
providing the information required by these regulations and is permitted to
customize the CGAD to provide the most relevant information necessary to permit
the director to gain an understanding of the corporate governance structure,
policies and practices utilized by the insurer or insurance group.
D. For purposes of completing the CGAD, the
insurer or insurance group may choose to provide information on governance
activities that occur at the ultimate controlling parent level, an intermediate
holding company level and/or the individual legal entity level, depending upon
how the insurer or insurance group has structured its system of corporate
governance. The insurer or insurance group is encouraged to make the CGAD
disclosures at the level at which the insurer's or insurance group's risk
appetite is determined, or at which the earnings, capital, liquidity,
operations, and reputation of the insurer are overseen collectively and at
which the supervision of those factors are coordinated and exercised, or the
level at which legal liability for failure of general corporate governance
duties would be placed. If the insurer or insurance group determines the level
of reporting based on these criteria, it shall indicate which of the three
criteria was used to determine the level of reporting and explain any
subsequent changes in level of reporting.
E. Notwithstanding Subsection A of this
Section, and as outlined in Section
38-13-1020 of the Insurance Law,
if the CGAD is completed at the insurance group level, then it must be filed
with the lead state of the group as determined by the procedures outlined in
the most recent Financial Analysis Handbook adopted by the NAIC. In these
instances, a copy of the CGAD must also be provided to the chief regulatory
official of any state in which the insurance group has a domestic insurer, upon
request.
F. An insurer or insurance
group may comply with this section by referencing other existing documents
(e.g., ORSA Summary Report, Holding Company Form B or F filings, Securities and
Exchange Commission (SEC) Proxy Statements, foreign regulatory reporting
requirements, etc.) if the documents provide information that is comparable to
the information described in Section V. The insurer or insurance group shall
clearly reference the location of the relevant information within the CGAD and
attach the referenced document if it is not already filed or available to the
regulator.
Section V.
Contents of Corporate Governance Annual Disclosure
A. The insurer or insurance group shall be as
descriptive as possible in completing the CGAD, with inclusion of attachments
or example documents that are used in the governance process, since these may
provide a means to demonstrate the strengths of their governance framework and
practices.
B. The CGAD shall
describe the insurer's or insurance group's corporate governance framework and
structure including consideration of the following.
(1) The Board and various committees thereof
ultimately responsible for overseeing the insurer or insurance group and the
level(s) at which that oversight occurs (e.g., ultimate control level,
intermediate holding company, legal entity, etc.). The insurer or insurance
group shall describe and discuss the rationale for the current Board size and
structure; and
(2) The duties of
the Board and each of its significant committees and how they are governed
(e.g., bylaws, charters, informal mandates, etc.), as well as how the Board's
leadership is structured, including a discussion of the roles of Chief
Executive Officer (CEO) and Chairman of the Board within the
organization.
C. The
insurer or insurance group shall describe the policies and practices of the
most senior governing entity and significant committees thereof, including a
discussion of the following factors:
(1) How
the qualifications, expertise and experience of each Board member meet the
needs of the insurer or insurance group.
(2) How an appropriate amount of independence
is maintained on the Board and its significant committees.
(3) The number of meetings held by the Board
and its significant committees over the past year as well as information on
director attendance.
(4) How the
insurer or insurance group identifies, nominates and elects members of the
Board and its committees. The discussion should include, for example:
(a) Whether a nomination committee is in
place to identify and select individuals for consideration
(b) Whether term limits are placed on
directors
(c) How the election and
re-election processes function.
(d)
Whether a Board diversity policy is in place and if so, how it
functions.
(5) The
processes in place for the Board to evaluate its performance and the
performance of its committees, as well as any recent measures taken to improve
performance (including any Board or committee training programs that have been
put in place).
D. The
insurer or insurance group shall describe the policies and practices for
directing Senior Management, including a description of the following factors:
(1) Any processes or practices (i.e.,
suitability standards) to determine whether officers and key persons in control
functions have the appropriate background, experience and integrity to fulfill
their prospective roles, including:
(a)
Identification of the specific positions for which suitability standards have
been developed and a description of the standards employed.
(b) Any changes in an officer's or key
person's suitability as outlined by the insurer's or insurance group's
standards and procedures to monitor and evaluate such changes.
(2) The insurer's or insurance
group's code of business conduct and ethics, the discussion of which considers
for example:
(a) Compliance with laws, rules,
and regulations; and
(b) Proactive
reporting of any illegal or unethical behavior.
(3) The insurer's or insurance group's
processes for performance evaluation, compensation and corrective action to
ensure effective senior management throughout the organization, including a
description of the general objectives of significant compensation programs and
what the programs are designed to reward. The description shall include
sufficient detail to allow the director to understand how the organization
ensures that compensation programs do not encourage and/or reward excessive
risk taking. Elements to be discussed may include, for example:
(a) The Board's role in overseeing management
compensation programs and practices.
(b) The various elements of compensation
awarded in the insurer's or insurance group's compensation programs and how the
insurer or insurance group determines and calculates the amount of each element
of compensation paid.
(c) How
compensation programs are related to both company and individual performance
over time;
(d) Whether compensation
programs include risk adjustment and how those adjustments are incorporated in
to the program for employees at different levels;
(e) Any clawback provisions built into the
programs to recover awards or payments if the performance measures upon which
they are based are restarted or otherwise adjusted;
(f) Any other factors relevant in
understanding how the insurer or insurance group monitors its compensation
policies to determine whether its risk management objectives are met by
incentivizing its employees.
(4) The insurer's or insurance group's plans
for CEO and Senior Management succession.
E. The insurer or insurance group shall
describe the processes by which the Board, its committees and Senior Management
ensure an appropriate amount of oversight to the critical risk areas impacting
the insurer's business activities, including a discussion of:
(1) How oversight and management
responsibilities are delegated between the Board, its committees and Senior
Management;
(2) How the Board is
kept informed of the insurer's strategic plans, the associated risks, and steps
that Senior Management is taking to monitor and manage those risks;
(3) How reporting responsibilities are
organized for each critical risk area. The description should allow the
director to understand the frequency at which information on each critical risk
area is reported to and reviewed by Senior Management and the Board. This
description may include, for example, the following critical risk areas of the
insurer:
(a) Risk management processes (An
ORSA Summary Report filer may refer to its ORSA Summary Report pursuant to the
Risk Management and Own Risk and Solvency Assessment Model Act);
(b) Actuarial function;
(c) Investment decision-making
processes;
(d) Reinsurance
decision-making processes;
(e)
Business strategy/finance decision-making processes;
(f) Compliance function;
(g) Financial reporting/ internal auditing;
and
(h) Market conduct
decision-making processes.
Section VI. Severability Clause
If any provision of these regulations, or the application thereof
to any person or circumstance, is hold invalid, such determination shall not
affect other provisions or applications of these regulations which can be given
effect without the invalid provision or application, and to that end the
provision of these regulations are severable.